Medical Illness and Comorbidities in Drug Users: Implications for Addiction Pharmacotherapy Treatment

References

• Altice F. L., Friedland G. H., Cooney E. L. Nevirapine induced opiate withdrawl among injection drug users with HIV infection receiving methadone. AIDS 1999; 13(8)957–962, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• The Effectiveness of Methadone Maintenance Treatment, J. Ball, A. Ross. Springer-Verlag, New York 1991
   Google Scholar
• Barry M., Mulcahy F., Merry C., Gibbons S., Back D. Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clinical Pharmacokinetics 1999; 36: 289–304, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Baur C. R., Shankaran S., Bada H. S., Lester B., Wright L. L., Krause-Steinrauf H., Smeriglio V. L., Finnegan L. P., Maza P. L., Verter J. The Maternal Life Style Study: drug exposure during pregnancy and short term maternal outcomes. American Journal of Obstetrics and Gynecology 2002; 186(3)487–495, [CROSSREF]
   PubMedGoogle Scholar
• Berghella V., Lim P. J., Hill M. K., Cherpes J., Chennat J., Kaltenbach K. Maternal methadone dose and neonatal withdrawal. American Journal of Obstetrics and Gynecology 2003; 189(2)312–317, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Blank A. E., Caloir S., Rosado T. I., Wilets I. Linking substance abuse patients with a primary care provider: implications for managed care [abstract]. Association for Health Services Research 13th Annual Meeting. 1996; 31: 26
   Google Scholar
• Burstein G. R. Diagnosis and management of sexually transmitted disease pathogens among adolescents. Pediatrics in Review 2003; 24(3)75–82, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• HIV Prevention Strategic Plan Through 2005. Centers for Disease Control and Prevention (CDC), Atlanta, GA 2000
   Google Scholar
• Cami J., Farre M. Drug Addiction. New England Journal of Medicine 2003; 349(10)975–986, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carroll K. M., Nich C., Ball S. A., McCance E., Rounsaville B. J. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction 1998; 93: 713–727, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carroll K. M., Nich C., Ball S. A., McCance E. F., Frankforter T. L., Rounsaville B. J. One year follow-up of disulfiram and psychotherapy for cocaine-alcohol abusers: Sustained effects of treatment. Addiction 2000; 95: 1335–1349, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chafnoff T. J., Neuman K., Thornton C., Callaghan M. A. Screening for substance use in pregnancy: A practical approach for the primary care physician. American Journal of Obstetrics and Gynecology 2001; 184(4)752–758, [CROSSREF]
   PubMedGoogle Scholar
• Cobb M. N., Desai J., Brown L. S., Zannikos P. N., Rainey P. M. The effect of fluconazole on the clinical pharmacokinetics of methadone. Clinical Pharmacology and Therapeutics 1998; 63: 655–662, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cohen O. J., Fauci A. S. Current strategies in the treatment of HIV infection. Advances in Internal Medicine, 46: 207–246
   PubMedGoogle Scholar
• Cohn J. A. HIV-1 infection in injection users. Infectious Disease Clinics of North America 2002; 16(3)745–770, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Decker C. J., Laitinen L. M., Bridson G. W., Raybuck S. A., Tung R. D., Chaturvedi P. R. Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions. Journal of Pharmaceutical Sciences 1998; 87: 803–807, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R., Friedmann P., Goldberg D., Frischer M., Green S., Tunving K., Ljungberg B., Wodak A. Maintaining low HIV seroprevalence in populations of injection drug users. Journal of the American Midical Society 1994; 274: 1226–1231
   Google Scholar
• Dienstag J. L. Sexual and perinatal transmission of hepatitis C. Hepatology 1997; 26: 665–705, Suppl 1[CROSSREF]
   Google Scholar
• Dieperink E., Willenbring M., Ho S. Neuropsychiatric symptoms associated with Hepatitis C and interferon alpha: A review. American Journal of Psychiatry 2000; 157: 867–876, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Donahue J. G., Nelson K. E., Munoz A., Vlahov D., Rennie L. L., Taylor E. L., Saah A. J., Cohn S., Odaka N. J., Farzadegan H. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. American Journal of Epidemiology 1991; 134: 1206–1211, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Drozdick J., 3rd, Berghella V., Hill M., Kaltenbach K. Methadone trough levels in pregnancy. American Journal of Obstetrics and Gynecology 2002; 187(5)1184–1188, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Eap C. B., Bertschy G., Powell K., Baumann P. Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone. Journal of Clinical Psychopharmacology 1997; 17: 113–117, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Edlin B. R. Prevention and treatment of Hepatitis C in Injection Drug Users. Hepatology 2002; 36: 5210–5219, [CROSSREF]
   Google Scholar
• Eldred L. J., Wu A. W., Chaisson R. E., Moore R. D. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18(2)117–125, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Fauci A. S., Pantaleao G., Stanley S., Weissman D. Immunopathologic mechanisms of HIV infection. Annals of Internal Medicine 1996; 124(7)654–663, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Ferry L. H., Robbins A. S., Scariati P. D., Masterson A., Abbey D. E., Burchette R. J. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride (abstract). Circulation 1992; 86: 671
   Web of Science ®Google Scholar
• Frame P. T. HIV disease in primary care. Primary Care 2003; 30(1)205–237, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Friedmann P. D., Alexander J. A., Jin L., D'Aunno T. A. On-site primary care and mental health services in outpatient drug abuse treatment units. Journal of Behavioral Health Services and Research 1999; 26(1)80–94
   PubMed Web of Science ®Google Scholar
• Fried M. W. Side effects of therapy of Hepatitis C and their management. Hepatology 2002; 36: 5237–5244
   Google Scholar
• Fuller R. F., Branchey L., Brightwell D. R., Derman R. M., Emrick C. D., Iber F. L., James K. E., Lacoursiere R. B., Lee K. K., Lowenstein I., Maany I., Neiderhiser D., Nocks J. J., Shaw S. Disulfiram treatment of alcoholism: A Veteran's Administration cooperative study. Journal of the American Medical Association 1986; 256(11)1449–1455, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gatbutt J. C., West S. L., Carey T. S., Lohr K. N., Crews F. T. Pharmacological treatment of alcohol dependence: a review of the evidence. Journal of the American Medical Association 1999; 281(14)1318–1325, [CROSSREF]
   Google Scholar
• Gourevitch M. N., Friedland G. H. Interactions between methadone and medications used to treat HIV Infection: a review. Mount Sinai Journal of Medicine 2000; 67: 429–436, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Greenfield S. F. Epidemiology of substance use disorders in women. Obstetrics and Gynecology Clinics of North America 2003; 30(3)413–46, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Hagopian G. S., Wolfe H. M., Sokol R. J., Ager J. W., Wardell J. N., Cepeda E. E. Neonatal outcome following methadone exposure in utero. Journal of Maternal-Fetal Medicine 1996; 5(6)348–354, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Hald J., Jacobsen E., Larsen V. The sensitizing effect of tetraethylthiuram disulfide (Antabuse) to ethyl alcohol. Acta Pharmacologica Toxicologica 1948; 4: 285–296
   Google Scholar
• Hall S. M., Munoz R. F., Reus V. I., Sees K. L. Nicotine, negative affect, and depression. Journal of Consulting and Clinical Psychology 1993; 61(5)761–767, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hamilton S. P., Nunes E. V., Janal M., Weber L. The effect of sertraline on methadone plasma levels in methadone-maintenance patients. American Journal on Addictions 2000; 9: 63–69, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Helander A., Carlsson S. Use of leukocyte aldehyde dehydrogenase activity to monitor inhibitory effect of disulfiram treatment in alcoholism. Alcoholism, Clinical and Experimental Research 1990; 14: 48–52, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Herrlin K., Segerdahl M., Gustafsson L. L., Kalso E. Methadone, Ciprofloxacin and adverse drug reactions. Lancet 2000; 356(9247)2069–2070, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hsu A., Granneman G. R., Bert R. J. Ritonavir: Clinical pharmacokinetics and interactions with other anti-HIV agents. Clinical Pharmacokinetics 1998; 35: 275–291, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hsyu P. H., Lillibridge J. H., Maroldo L., Weiss W. R., Kerr B. M.. Pharmacokinetic (PK) and pharmacodynamic (PD) interactions between nelfinavir and methadone. 7th Conference on Retroviruses and Opportunistic Infections. 2000; 91
   Google Scholar
• Hulse G. K., O'Neill G. Methadone and the pregnant user: a matter for careful clinical consideration. Australian and New Zealand Journal of Obstetrics and Gynaecology 2001; 41(3)329–332, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Iribarne C., Berthou F., Baird S., Dreano Y., Picart D., Bail J. P., Beaune P., Menez J. F. Involvement of cytochrome P450 3!4 enzyme in the n-demethylation of methadone in human liver microsomes. Chemical Research in Toxicology 1996; 9: 365–373, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Iribarne C., Picart D., Dreano Y., Berthou F. In vitro interactions between fluoxetine or fluvoxamine and methadone or Buprenorphine. Fundamental and Clinical Pharmacology 1998A; 12: 194–199
   PubMed Web of Science ®Google Scholar
• Iribarne C., Berthou F., Carlhant D., Dreano Y., Picart D., Lohezic F., Riche C. Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors. Drug Metabolism and Disposition 1998; 26: 257–260, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jarvis M. A., Wu-Pong S., Knisely J. S., Schnoll S. H. Alterations in methadone metabolism during late pregnancy. Journal of Addictive Disease 1999; 18(4)51–61, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jin C., McCance-Katz E. F. Cocaine use disorders. Psychiatry. 2nd ed., A. Tasman, J. Kay, J. A. Lieberman. W. B. Saunders, Philadelphia 2003; 1: 1010–1036
   Google Scholar
• Johnson R. E., Chutuape M. A., Strain E. C., Walsh S. L., Stitzer M. L., Bigelow G. E. A. comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 2000; 343: 1290–1297, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Johnson R. E., Jones H. E., Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug and Alcohol Dependence 2003; 70: 87–101, Suppl. 2[CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kanno M. B., Zenilman J. Sexually transmitted diseases in injection drug users. Infectious Disease Clinics of North America 2002; 16(3)771–780, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Katlenbach K., Berghelle V., Fiinegan L. Substance abuse in pregnancy: opioid dependence, drug effects and management. Obstetrics and Gynecology Clinics 1998; 25(1)139–151
   PubMedGoogle Scholar
• Klesges L. M., Johnson K. C., Ward K. D., Barnard M. Smoking cessation in pregnant women. Obstetrics and Gynecology Clinics of North America 2001; 28(2)269–282, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Kraus M. R., Shafer A., Faller H., Csef H., Scheurlen M. Psychiatric symptoms in patients with chronic Hepatitis C receiving interferon alpha-2b therapy. Journal of Clinical Psychiatry 2003; 64(6)708–714, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lejeune C., Aubisson S., Simmal-Durand L., Cneude F., Piquet M., Gourarier L. Groupe d'Etudes Grossesse et addictions. Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases. Annals of Internal Medicine 2001; 152: 21–27, Suppl 7
   Google Scholar
• Lemberg B. D. Hepatic disease in injection drug users. Infectious Disease Clinics of North America 2002; 18(3)667–679, [CROSSREF]
   Google Scholar
• Lerner B. H., Gulick R. M., Dubler N. N. Rethinking nonadherence: Historical perspectives on triple drug therapy for HIV disease. Annals of Internal Medicine 1998; 129: 573–578, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lester B. M., El Sohly M., Wright L. L., Smeriglio V. L., Verter J., Bauer C. R., Shankaran S., Bada H. S., Walls H. H., Huestis M. A., Finnegan L. P., Maza P. L. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self report. Pediatrics 2001; 107(2)309–317, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Luty J., Niklaou V., Bean J. Is opiate detoxification unsafe in pregnancy?. Journal of Substance Abuse Treatment 2003; 24(4)363–367, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Morbidity a nd, Mortality Weekly Report, 1987–1990. Crack cocaine use among persons with tuberculosis – Contra Costa County, California. Morbity and Mortality Weekly Report 1991; 40: 485–489
   PubMedGoogle Scholar
• McCance-Katz E. F., Selwyn P., Farber S., O'Connor A. H. The protease inhibitor nelfinavir decreases methadone levels. American Journal of Psychiatry 2000; 157: 481, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz E. F., Kosten T. R., Jatlow P. I. Disulfiram effects on acute cocaine administration. Drug and Alcohol Dependence 1998; 52: 27–39, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz E. F., Kosten T. R., Jatlow P. I. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone- a multiple-dose study. Biological Psychiatry 1998; 44: 250–259, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz E. F., Rainey P. M., Jatlow P., Friedland G. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998; 18: 435–443, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• McCance-Katz E. F., Gourevitch M. N., Arnsten J., Sarlo J., Rainey P., Jatlow P. Modified Directly Observed Therapy (MDOT) For Injection Drug Users With HIV Disease. American Journal on Addictions 2002; 11(4)271–278, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz E. F., Rainey P., Friedland G., Jatlow P. The protease inhibitor lopinavir/ritonavir may produce opiate withdrawal in methadone-maintained patients. Clinical Infectious Diseases 2003; 37: 476–482, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McCance-Katz E. F., Cropsey K., Gourevitch M. Responding to intravenous drug use (IDU) among people living with HIV/AIDS-An international review. World Health Organization, GenevaSwitzerland, In press
   Google Scholar
• McCance-Katz E. F., Rainey P., Smith P., Morse G., Friedland G., Gourevitch M., Jatlow P. Drug interactions between opioid and antiretroviral medications: Interaction between methadone, LAAM, and nelfinavir. American Journal on Addictions 2004; 13: 163–180, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McHutchison J. G., Fried M. W. Current therapy for hepatitis C: Pegylated interferon and ribavirin. Clinics in Liver Disease 2003; 7(1)149–161, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• McLellan A. T., Hagan T. A., Levine M., Gould F., Meyers K., Bencivengo M., Durell J. Supplemental social services improve outcomes in public addiction treatment. Addiction 1998; 93(10)1489–1499, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miller N. H. Compliance with treatment regimens in chronic asymptomatic diseases. American Journal of Medicine 1997; 102(2A)43–49, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Musselman D. L., Lawson D. H., Gumnick J. F., Manatunga A. K., Penna S., Goodkin R. S., Greiner K., Nemeroff C. B., Miller A. H. Paroxitine for the prevention of depression induced by high-dose interferon alpha. New England Journal of Medicine 2001; 344(13)961–966, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nevins C. L., Malaty H., Velez M., Anand B. S. Interaction of alcohol and Hepatitis C virus on severity of liver disease. Digestive Diseases and Sciences 1999; 44(6)1236–1242, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• O'Conner P. G., Selwyn P. A., Schottenfield R. S. Medical care for injection-drug users with human immunodeficiency virus infection. New England Journal of Medicine 1994; 18: 450–459
   Google Scholar
• O'Connor P. G., Oliveto A. H., Shi J. M., Triffleman E. G., Carroll K. M., Kosten T. R., Rounsaville B. J., Pakes J. A., Schottenfeld R. S. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine 1998; 105(2)100–105, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Physicians' Desk Reference. Thompson PDR, Montvale, NJ 2003; 1678–1682
   Google Scholar
• Pawlotsky J. M. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clinics in Liver Disease 2003; 7(1)89–105, [CROSSREF]
   PubMedGoogle Scholar
• Philipp B. L., Merewood A., O'Brien S. Methadone and breastfeeding: new horizans. Pediatrics 2003; 111(6)1429–1430, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Pond S. M., Kreek M. J., Tong T. G., Raghunath J., Benowitz N. L. Altered methadone pharmacokinetics in methadone-maintained pregnant women. Journal of Pharmacology and Experimental Therapeutics 1985; 233: 1–6, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Rainey P. M., Friedland G. H., Snidow J. W., McCance-Katz E. F., Mitchell S. M., Andrews L., Lane B., Jatlow P. The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate dependent subjects (NZTA4003). American Journal on Addictions 2002; 11(1)66–74, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rainey P. M., Friedland G., McCance-Katz E. F., Andrews L., Mitchell S. M., Charles C., Jatlow P. Interaction of methadone with didanosine and stavudine. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 2000; 24: 241–248
   Google Scholar
• Revised Guidelines for HIV Counseling, Testing, and Referral. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report. CDC, Atlanta, GA 2001; 1–57, 50 (RR-19)
   Google Scholar
• Rosenbach K. A. HAART simplification. MD Consult Clinical Insights. 2003, www.mdconsults.com Accessed 2004
   Google Scholar
• Saitz R., Mulvey K. P., Samat J. H. The substance abusing patient and primary care: linkage via the addiction treatment system?. Substance Abuse 1997; 18: 187–195
   Google Scholar
• Samet J. H., Friedmann P., Saitz R. Benefits of Linking Primary Medical Care and Substance Abuse Services. Patient, Provider, and Societal Perspectives. Archives of Internal Medicine 2001; 161(1)85–91, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sarbah S., Mullen K. Risk factors for viral hepatitis B and C help identify disease. Practical Gastroenterolology 1998; 22: 10–26
   Google Scholar
• Sarbah S., Younossi Z. Hepatitis C: An update on the silent epidemic. Journal of Clinical Gastroenterology 2000; 30(2)125–143, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Saxon A. J., Whittaker S., Hawker C. S. Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases. Journal of Clinical Psychiatry 1989; 50: 228–229, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schiff E. R. Hepatitis C and alcohol. Hepatology 1997; 26: 395–425, Suppl 1[CROSSREF]
   Google Scholar
• Schindler S. D., Eder H., Ortner R., Rohrmeister K., Langer M., Fischer G. Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy. Addiction 2003; 98(1)103–110, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schlenger W. E., Kroutl L. A., Roland E. J. Case management for linking drug abuse treatment and primary care: preliminary evidence from the ADAMHA/HRSA linkage demonstration. Progress and Issues in Case Management. DHHS Publication No. 92-1946, U.S. Dept of Health and Human Services, Rockville, MD 1992
   Google Scholar
• Schwartz M., Baker G., Mulvey K. P., Plough A. Improving publicly funded substance abuse treatment: the value of case management. American Journal of Public Health 1997; 87(10)1659–1664
   PubMed Web of Science ®Google Scholar
• Seef L. B. Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002. Clinics in Liver Disease 2003; 7(1)261–287, [CROSSREF]
   PubMedGoogle Scholar
• Sellers E., Lam R., McDowell J., Corrigan B., Hedayetullah N., Somer G., Kirby L., Kersey K., Yuen G. The Pharmacokinetics of Abacavir and Methadone Following Co-administration: CNAA1012. 1999, American Society for Microbiology 39th ICAAC Program On-Line
   Google Scholar
• Smith M. Y., Rapkin B. D., Morrison A. Zidovudine adherence in persons with AIDS: The relation of patient beliefs about medication to self termination of therapy. Journal of General Internal Medicine 1997; 12: 216–223, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stone V. E., Clarke J., Lowell J., Steger K. A., Hirschhom L. R., Boswell S., Monroe A. D., Stein M. D., Tyree J., Mayer K. H. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. Journal of General Internal Medicine 1998; 13(9)586–593, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Teitelbaum M., Walker A., Gabay M., Gross M., Mason T., Weitzman E. Analysis of Barriers to the Delivery of Integrated Primary Care Services and Substance Treatment: Case Studies of Nine Linkage Program Projects. Abt Associates Inc., Bethesda, MD 1992
   Google Scholar
• Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents 2003. US Department of Health and Human Services. 2003, http://aidsinfo.nih.gov/guidelines Accessed 2004.
   Google Scholar
• UNAIDS Asia Pacific Intercountry Team. Drug use and HIV vulnerability, policy research study in Asia. Task Force on Drug Use and HIV Vulnerability, BangkokThailand 2000
   Google Scholar
• Umbricht-Schneiter A., Ginn D. H., Pabst K. M., Bigelow G. E. Providing medical care to methadone clinic patients: referral vs. on-site care. American Journal of Public Health 1994; 84(2)207–210, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Van Thiel D. H., Friedlander L., Molloy P. J., Fagiuoli S., Kania R. J., Caraceni P. Interferon-alpha can be used successfully in patients with Hepatits C virus-positive chronic hepatitis who have a psychiatric illness. European Journal of Gastroenterology and Hepatology 1995; 7(2)165–168, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Trends in Substance Use and Associated Health Problems. Fact Sheet No. 127, World Health Organization, GenevaSwitzerland 1996
   Google Scholar
• World Health Organization. World Health Report 2002, http://www.who.org Accessed 2004
   Google Scholar
• Wiley T. E., McCarty M., Briedi L. Impact of alcohol on the histological and clinical progression of Hepatitis C infection. Hepatology 1998; 28: 805–809, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Willenbring M. L., Olson D. H. A randomized trial of integrated outpatient treatment for medically ill alcoholic men. Archives of International Medicine 1999; 159(16)1946–1952, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wood E., Montaner J. S., Yip B., Tyndall M. W., Schecter M. T., O'Shaughnessy M. V., Hogg R. S. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal 2003; 169(7)656–661, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Workowski K. A., Leone W. C. Sexually transmitted disease guidelines 2002. Morbity and Mortality Weekly Report 2002; 51, (RR-6)
   Google Scholar
• Wright C., Moore R. D. Disulfiram treatment of alcoholism. American Journal of Medicine 1990; 88(6)647–655, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar